Document Detail


Sumatriptan therapy for headache and acute myocardial infarction.
MedLine Citation:
PMID:  20977405     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
IMPORTANCE OF THE FIELD: Migraine is a common, debilitating, chronic neurovascular disorder. Triptans are considered the drugs of choice to treat migraine attacks; however, their use is limited owing to concerns about cardiovascular safety.
AREAS COVERED IN THIS REVIEW: The aim of this review is to describe: the mechanisms of action of triptans; the case-reports of acute myocardial infarction (AMI) associated with sumatriptan use; and the results of studies evaluating its tolerability and safety.
WHAT THE READER WILL GAIN: Sumatriptan administration can be followed, in close temporal relationship, by AMI in young or adult migraine patients. Some of these cases have developed in subjects taking their first dose. Based on the results of prospective studies, the risk of severe cardiovascular adverse events after the use of a triptan is estimated at 1:100,000 treated attacks. These adverse events, albeit very infrequent, highlight the importance of careful adherence to the sumatriptan prescribing information.
TAKE HOME MESSAGE: Inherent in its mechanism of action, sumatriptan could produce (coronary) vasospasm sometimes followed by AMI. The drug should not be prescribed to patients with history, symptoms or signs of ischemic vascular disease; an in-depth evaluation should be carried out in subjects at intermediate cardiovascular risk.
Authors:
Silvia Barra; Simona Lanero; Alfredo Madrid; Crescenzo Materazzi; Giancarlo Vitagliano; Paul R J Ames; Giovanni Gaeta
Related Documents :
3687775 - Heart rate variability as an index of sympathovagal interaction after acute myocardial ...
2090725 - Computerized recognition of acute infarction. criteria advances and test results.
20467155 - Association between circulating monocytes and coronary plaque progression in patients w...
8248465 - The influence of psychosocial factors on survival after myocardial infarction.
24385385 - Inotropic agents and vasodilator strategies for acute myocardial infarction complicated...
1630795 - A methodology for qi in the coronary artery bypass grafting procedure involving compara...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Expert opinion on pharmacotherapy     Volume:  11     ISSN:  1744-7666     ISO Abbreviation:  Expert Opin Pharmacother     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-10-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100897346     Medline TA:  Expert Opin Pharmacother     Country:  England    
Other Details:
Languages:  eng     Pagination:  2727-37     Citation Subset:  IM    
Affiliation:
Antonio Cardarelli Hospital, Cardiology Unit, Via Antonio Cardarelli, 9, 80131 Naples, Italy. giovanni.gaeta@tin.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The role of zoledronic acid in the adjuvant treatment of breast cancer: current perspectives.
Next Document:  Sevelamer carbonate for the treatment of hyperphosphatemia in patients with kidney failure (CKD III ...